MedPath
NMPA Approval

Ranibizumab Injections

国药准字S20240034

August 13, 2024

Drug Information

雷珠单抗注射液

安卓明

注射剂

10mg/ml,每瓶装量0.20ml。

生物制品

August 13, 2024

Company Information

Applicant Company

山东省济南市高新区新泺大街317号

Manufacturing Company

山东省济南市高新区旅游路8888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

雷珠单抗注射液 - NMPA 批准文号 | MedPath